Targeted Sequencing Market by Technology Type (Amplicon Sequencing, Custom Targeted Sequencing, Hybridization-based Targeted Sequencing), Application (Agricultural Genomics, Clinical Diagnostics, Drug Discovery), End User, Product and Services, Instrument Type - Global Forecast 2025-2030

The Targeted Sequencing Market size was estimated at USD 6.23 billion in 2023 and expected to reach USD 7.60 billion in 2024, at a CAGR 20.30% to reach USD 22.73 billion by 2030.

Targeted sequencing focuses on analyzing specific regions of interest within a genome rather than the entire genomic landscape, allowing researchers to concentrate on the most relevant DNA sequences for their studies. This method is essential in various applications including genetic disease diagnosis, personalized medicine, forensic analysis, and agricultural development. By targeting specific areas, this technique can be more cost-effective and time-efficient compared to whole-genome sequencing, making it indispensable in healthcare and pharmaceutical industries where quick and accurate results are critical. The rising prevalence of genetic disorders, advancements in sequencing technologies, and increased funding for genomics research are key factors driving the growth of the targeted sequencing market. There are ample opportunities in personalized medicine, where targeted sequencing helps in understanding genetic variations that influence drug responses, paving the way for the development of tailor-made therapies. However, the market faces challenges such as ethical concerns around genetic data privacy, high costs associated with technological setup, and the need for specialized expertise to analyze complex genetic data. Companies can innovate by developing more robust bioinformatics tools to simplify data analysis and improve the sensitivity and specificity of sequencing technologies. Continuous R&D to lower the cost of sequencing and expand its accessibility can further market reach. The market is highly dynamic, with constant technological advancements and shifting regulatory environments that can impact growth trajectories. Investing in collaborative research initiatives and forming strategic partnerships with biopharmaceutical firms can provide market participants with a competitive edge. Despite its challenges, the targeted sequencing market offers promising opportunities for innovation, specifically in enhancing precision medicine applications and expanding genetic understanding across diverse populations. Businesses should focus on R&D to address existing limitations, aiming to deliver more efficient and accurate diagnostic solutions tailored to individual genetic profiles.

The market dynamics represent an ever-changing landscape of the Targeted Sequencing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • Advancements in sequencing technology enhance the precision and cost-effectiveness of targeted sequencing
  • Growing awareness of the benefits of early genetic testing by consumers propels targeted sequencing market
  • Increased use of targeted sequencing in agriculture for crop improvement and pest resistance boosts market growth
• Market Restraints
  • Quality control issues and reproducibility concerns limiting the widespread use of targeted sequencing
  • Data privacy and ethical concerns hindering the collection, storage, and use of genomic data
  • Regulatory and compliance hurdles that complicate market entry and expansion for targeted sequencing
• Market Opportunities
  • Emerging markets worldwide present untapped opportunities for expansion in targeted sequencing
  • Expansion of direct-to-consumer genetic testing services bolstering market potential for targeted sequencing
  • Rising prevalence of infectious diseases creating increased reliance on targeted sequencing for pathogen identification
• Market Challenges
  • Addressing data privacy concerns and ethical considerations in targeted sequencing research
  • Tackling limited awareness and understanding among healthcare providers and patients about targeted sequencing
  • Assessing the impact of technological advancements on existing infrastructure for targeted sequencing

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Targeted Sequencing Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

The PESTLE analysis offers a comprehensive tool for understanding and analyzing the external macro-environmental factors that impact businesses within the Targeted Sequencing Market. This framework examines Political, Economic, Social, Technological, Legal, and Environmental factors, providing companies with insights into how these elements influence their operations and strategic decisions. By using PESTLE analysis, businesses can identify potential opportunities and threats in the market, adapt to changes in the external environment, and make informed decisions that align with current and future conditions. This analysis helps companies anticipate shifts in regulation, consumer behavior, technology, and economic conditions, allowing them to better navigate risks and capitalize on emerging trends.

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Targeted Sequencing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Targeted Sequencing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Targeted Sequencing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

The report delves into recent significant developments in the Targeted Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., A-Alpha Bio, Inc., Agilent Technologies, Inc., Azenta Life Sciences, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., CD Genomics, DH Life Sciences, LLC, Element Biosciences, F. Hoffmann-La Roche Ltd., Illumina, Inc., LGC Limited, Macrogen, Inc., MGI Tech Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Paragon Genomics, Inc., PerkinElmer, Inc., Psomagen, Inc., QIAGEN N.V., Singular Genomics Systems, Inc., Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

This research report categorizes the Targeted Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Technology Type
  • Amplicon Sequencing
    • PCR-based Amplification
    • Probe-based Multiplex Amplification
  • Custom Targeted Sequencing
    • Customized Panel Design
    • Flexible Custom Sequencing
  • Hybridization-based Targeted Sequencing
    • Capture-based Techniques
    • Enrichment-based Approaches
• Application
  • Agricultural Genomics
    • Crop Improvement
    • Livestock Enhancement
  • Clinical Diagnostics
    • Cancer Genomics
    • Inherited Disease Detection
  • Drug Discovery
    • Preclinical Trials
    • Target Identification
  • Personalized Medicine
    • Individualized Treatment
    • Pharmacogenomics
• End User
  • Biotechnology Companies
    • Clinical Trials
    • Product Development
  • Hospitals and Clinics
    • In-house Testing
    • Outsourced Services
  • Research Laboratories
    • Academic Institutions
    • Government Organizations
• Product and Services
  • Kits and Reagents
    • Customizable Reagent Packs
    • Ready-to-use Kits
  • Software and Services
    • Bioinformatics Services
    • Data Analysis Software
• Instrument Type
  • Library Preparation Systems
    • Automated Systems
    • Manual Workstations
  • Sequencing Platforms
    • Next-generation Sequencers
    • Real-time Sequencers

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

1. What is the current market size and projected growth?
2. Which products, segments, applications, and regions offer promising investment opportunities?
3. What are the prevailing technology trends and regulatory frameworks?
4. What is the market share and positioning of the leading vendors?
5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?